captopril has been researched along with EHS Tumor in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Kazimierczak, U; Kowalczyk, DW; Kwiatkowska, EP; Mackiewicz, A; Suchorska, W; Wysocki, PJ | 1 |
1 other study(ies) available for captopril and EHS Tumor
Article | Year |
---|---|
Captopril, an angiotensin-converting enzyme inhibitor, promotes growth of immunogenic tumors in mice.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Captopril; CD8-Positive T-Lymphocytes; Cell Line, Tumor; Cell Survival; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Female; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Mice, SCID; Sarcoma, Experimental; Transplantation, Heterologous; Xenograft Model Antitumor Assays | 2006 |